Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  Lactobacillus brevis CD2 lozenge
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
CD2 Lozenges in Preventing Acute Oral Mucositis in Patients with Head and Neck Cancer Receiving Radiotherapy and Chemotherapy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: N11C5, NCI-2012-00692, CDR0000727295, NCCTG-N11C5, NCT01545687
Start Over